Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 40 of 1,261
  1. US 12310997

    Compositions and methods of treating ocular diseases

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  2. US 12312411

    Anti-CD38 binding domains

    Takeda Pharmaceutical Company Limited · Granted May 27, 2025 · Expires May 22, 2045

    granted
  3. US 12312345

    Fluoroalkyl-oxadiazoles and uses thereof

    Tenaya Therapeutics, Inc. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  4. US 12310992

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted May 27, 2025 · Expires May 22, 2045

    granted
  5. US 12311054

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University · Granted May 27, 2025 · Expires May 22, 2045

    granted
  6. US 12312377

    Biconjugatable labels and methods of use

    Quantum-Si Incorporated · Granted May 27, 2025 · Expires May 22, 2045

    granted
  7. US 12310943

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA · Granted May 27, 2025 · Expires May 22, 2045

    granted
  8. US 12311053

    Nanotube-vesicle compositions and uses thereof

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  9. US 12310956

    Topical roflumilast formulation having improved delivery and plasma half-life

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  10. US 12312357

    PRMT5 inhibiting compounds and uses thereof

    ANTENGENE DISCOVERY LIMITED · Granted May 27, 2025 · Expires May 22, 2045

    granted
  11. US 12312616

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  12. US 12310965

    Treatment of cancer utilizing an identified adenosine fingerprint

    Arcus Biosciences, Inc. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  13. US 12311030

    Antibody-sting agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted
  14. US 12310954

    Salivary gland regeneration

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  15. US 12312375

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted May 27, 2025 · Expires May 22, 2045

    granted
  16. US 12311169

    Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  17. US 12312348

    RET inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  18. US 12310968

    Chiral diaryl macrocycles and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  19. US 12311029

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Northwestern University · Granted May 27, 2025 · Expires May 22, 2045

    granted
  20. US 12310934

    Methods of treatment of spontaneous preterm birth

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  21. US 12313635

    Biomarker for thoracic aortic aneurysm

    The Regents of the University of California · Granted May 27, 2025 · Expires May 22, 2045

    granted
  22. US 12311016

    Biomarkers and immunogenic compositions for filarial parasites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2025 · Expires May 22, 2045

    granted
  23. US 12312589

    RNA-nanostructured double robots and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 27, 2025 · Expires May 22, 2045

    granted
  24. US 12310986

    Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress

    The Board of Regents of the University of Texas System · Granted May 27, 2025 · Expires May 22, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.